2. GPCR/G Protein Neuronal Signaling Others
  3. Orexin Receptor (OX Receptor) Isotope-Labeled Compounds
  4. Tebideutorexant

Tebideutorexant  (Synonyms: JNJ-61393215)

Cat. No.: HY-147403S Purity: 98.95%
COA
SDS
Handling Instructions Technical Support

Tebideutorexant is an OX1R-selective inhibitor with oral bioavailability and blood-brain barrier permeability, with human OX1R pKi 8.17 and rat OX1R pKi 8.13.Tebideutorexant selectively modulates OX1R, with no significant functional effect on OX2R. Tebideutorexant can be used for the research of panic and anxiety disorders.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Tebideutorexant

Tebideutorexant 화학구조

CAS No. : 1637681-55-0

사이즈 가격 재고 수량
1 mg 견적 받기 2-4 weeks 2-4 weeks 2-4 weeks 2-4 weeks
5 mg 견적 받기 2-4 weeks 2-4 weeks 2-4 weeks 2-4 weeks
10 mg 견적 받기 2-4 weeks 2-4 weeks 2-4 weeks 2-4 weeks
50 mg   견적 받기  
100 mg   견적 받기  
Synthetic products have potential research and development risk.

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 Customer Validation

Tebideutorexant Related Antibodies

Top Publications Citing Use of Products

View All Orexin Receptor (OX Receptor) Isoform Specific Products:

View All Isoforms
OX2 Receptor OX1 Receptor

  • Biological Activity

  • 순도&문서

  • References

  • 고객리뷰

제품 설명

Tebideutorexant is an OX1R-selective inhibitor with oral bioavailability and blood-brain barrier permeability, with human OX1R pKi 8.17 and rat OX1R pKi 8.13.Tebideutorexant selectively modulates OX1R, with no significant functional effect on OX2R. Tebideutorexant can be used for the research of panic and anxiety disorders[1].

Application

1. This compound can be used as a tracer.
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

Cellular Effect
Cell Line Type Value Description References
Vero C1008 IC50
>2.0 × 105M
Compound: COVC-2283598831
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
10.6019/CHEMBL4651402
In Vitro

Tebideutorexant (JNJ-61393215) exhibits high affinity, potency, and selectivity for human and rat OX1R over OX2R and other molecular targets in vitro[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Tebideutorexant Related Antibodies
Parmacokinetics
Species Dose Route Plasma Concentration
Rat[1] 0.1, 1, 10 mg/kg p.o. 34 ng/mL
Rat[1] 10, 30 mg/kg p.o. 535 ng/mL
In Vivo

Tebideutorexant (3-30 mg/kg; p.o., single dose) dose-dependently blocks CO2-induced fear and bradycardia in rats, with efficacy at 10 and 30 mg/kg[1].
Tebideutorexant (0.1-10 mg/kg; p.o.) shows dose- and time-dependent brain OX1R occupancy in rats, with oral bioavailability and brain penetration[1].
Tebideutorexant (10 mg/kg; p.o.) reduces NREM and REM sleep latency without altering total sleep duration in rats[1].
Tebideutorexant (30 mg/kg; p.o.) selectively promotes REM sleep in OX2R KO mice, demonstrating in vivo OX1R target engagement[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (male, 300-400 g)[1]
Dosage: 3, 10, 30 mg/kg
Administration: p.o., single dose
Result: Blocked CO₂-induced reduction in social interaction behaviors at 10 and 30 mg/kg; attenuated CO₂-induced bradycardia responses at 8 and 9 minutes post-challenge at 30 mg/kg.
Animal Model: Sprague-Dawley (male, 300-400 g)[1]
Dosage: 0.1, 1, 10 mg/kg
Administration: p.o., single dose
Result: Produced time- and dose-dependent brain OX1R occupancy; reached 89% maximal occupancy at 15 minutes and remained above 47% for 8 hours at 10 mg/kg; achieved plasma EC50 of 34 ng/mL for 50% occupancy.
Animal Model: Sprague-Dawley (male, 350-450 g)[1]
Dosage: 10 mg/kg
Administration: p.o., single dose
Result: Did not alter total NREM or REM sleep duration; significantly decreased NREM and REM sleep latency.
Animal Model: C57Bl6 OX2R knockout (male, 30-35 g, OX2R KO model)[1]
Dosage: 30 mg/kg
Administration: p.o., single dose
Result: Significantly reduced REM sleep latency; prolonged REM sleep duration in the first 2 hours post-treatment; showed no effect on NREM sleep parameters.
분자량

460.42

화학식

C23H16D2F4N4O2
CAS No.
Unlabeled CAS
Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=C(C2=NC=CC=N2)C(F)=CC=C1)N3[C@@H]4[C@@H](C[C@H](C3([2H])[2H])C4)OC5=CC=C(C=N5)C(F)(F)F
선적

Room temperature in continental US; may vary elsewhere.
보관
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
순도&문서
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Tebideutorexant Related Classifications

  • 몰농도 계산기

  • 농도 희석 계산기

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Tebideutorexant1637681-55-0JNJ-61393215JNJ61393215JNJ 61393215Orexin Receptor (OX Receptor)Isotope-Labeled CompoundsHypocretin ReceptorHCRT Receptorhuman OX1Rrat OX1Rpanic disordersOX2ROX1ROX2R KO miceanxiety disordersanxiety symptomspanic-like behaviorratsInhibitorinhibitorinhibit

최근 본 상품:

온라인 문의

Your information is safe with us. * Required Fields.

상품명

  

Requested Quantity *

고객명 *

 

호칭

메일주소 *

 

전화번호 *

Department

 

회사명 *

City

도

Country or Region *

      

비고

대량구매 문의

Inquiry Information

상품명:
Tebideutorexant
Cat. No.:
HY-147403S
수량:
MCE Japan Authorized Agent:

고객리뷰

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

상품명

  

Lot #

고객명 *

 

메일주소 *

전화번호

 

Department *

회사명 *

 

Country or Region *

비고

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.